12,939 results match your criteria Pediatrics Inborn Errors of Metabolism


The clinical presentation of cobalamin-related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathways.

J Inherit Metab Dis 2018 Dec 27. Epub 2018 Dec 27.

Division of Metabolism and Children's Research Center, University Children's Hospital Zürich, Zürich, Switzerland.

This review gives an overview of clinical characteristics, treatment and outcome of nutritional and acquired cobalamin (Cbl; synonym: vitamin B12) deficiencies, inborn errors of Cbl absorption and intracellular trafficking, as well as methylenetetrahydrofolate dehydrogenase (MTHFD1) and methylene tetrahydrofolate reductase (MTHFR) deficiencies, which impair Cbl-dependent remethylation. Acquired and inborn Cbl-related disorders and MTHFR deficiency cause multisystem, often severe disease. Failure to thrive, neurocognitive or psychiatric symptoms, eye disease, bone marrow alterations, microangiopathy and thromboembolic events are characteristic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jimd.12012DOI Listing
December 2018
1 Read

Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.

J Inherit Metab Dis 2019 Jan 12. Epub 2019 Jan 12.

Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.

SLC35A2-CDG is caused by mutations in the X-linked SLC35A2 gene encoding the UDP-galactose transporter. SLC35A2 mutations lead to hypogalactosylation of N-glycans. SLC35A2-CDG is characterized by severe neurological symptoms and, in many patients, early-onset epileptic encephalopathy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jimd.12055DOI Listing
January 2019
1 Read

Newborn screening for homocystinurias: Recent recommendations versus current practice.

J Inherit Metab Dis 2019 Jan;42(1):128-139

Austrian Newborn Screening, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Purpose: To assess how the current practice of newborn screening (NBS) for homocystinurias compares with published recommendations.

Methods: Twenty-two of 32 NBS programmes from 18 countries screened for at least one form of homocystinuria. Centres provided pseudonymised NBS data from patients with cystathionine beta-synthase deficiency (CBSD, n = 19), methionine adenosyltransferase I/III deficiency (MATI/IIID, n = 28), combined remethylation disorder (cRMD, n = 56) and isolated remethylation disorder (iRMD), including methylenetetrahydrofolate reductase deficiency (MTHFRD) (n = 8). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jimd.12034DOI Listing
January 2019
7 Reads

International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.

J Inherit Metab Dis 2019 Jan;42(1):5-28

Department of Clinical Genomics, Mayo Clinic, Rochester, New York.

Phosphomannomutase 2 (PMM2-CDG) is the most common congenital disorder of N-glycosylation and is caused by a deficient PMM2 activity. The clinical presentation and the onset of PMM2-CDG vary among affected individuals ranging from a severe antenatal presentation with multisystem involvement to mild adulthood presentation limited to minor neurological involvement. Management of affected patients requires a multidisciplinary approach. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jimd.12024DOI Listing
January 2019
1 Read

Mitochondrial disorders.

Ann Transl Med 2018 Dec;6(24):475

Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Primary mitochondrial disorders are a group of clinically variable and heterogeneous inborn errors of metabolism (IEMs), resulting from defects in cellular energy, and can affect every organ system of the body. Clinical presentations vary and may include symptoms of fatigue, skeletal muscle weakness, exercise intolerance, short stature, failure to thrive, blindness, ptosis and ophthalmoplegia, nystagmus, hearing loss, hypoglycemia, diabetes mellitus, learning difficulties, intellectual disability, seizures, stroke-like episodes, spasticity, dystonia, hypotonia, pain, neuropsychiatric symptoms, gastrointestinal reflux, dysmotility, gastrointestinal pseudo-obstruction, cardiomyopathy, cardiac conduction defects, and other endocrine, renal, cardiac, and liver problems. Most phenotypic manifestations are multi-systemic, with presentations varying at different age of onset and may show great variability within members of the same family; making these truly complex IEMs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.12.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331360PMC
December 2018
1 Read

Glycogen metabolism and glycogen storage disorders.

Ann Transl Med 2018 Dec;6(24):474

Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Glucose is the main energy fuel for the human brain. Maintenance of glucose homeostasis is therefore, crucial to meet cellular energy demands in both - normal physiological states and during stress or increased demands. Glucose is stored as glycogen primarily in the liver and skeletal muscle with a small amount stored in the brain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.10.59DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331362PMC
December 2018
1 Read

Fatty acid oxidation disorders.

Ann Transl Med 2018 Dec;6(24):473

Department of Pediatrics and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.

Fatty acid oxidation disorders (FAODs) are inborn errors of metabolism due to disruption of either mitochondrial β-oxidation or the fatty acid transport using the carnitine transport pathway. The presentation of a FAOD will depend upon the specific disorder, but common elements may be seen, and ultimately require a similar treatment. Initial presentations of the FAODs in the neonatal period with severe symptoms include cardiomyopathy, while during infancy and childhood liver dysfunction and hypoketotic hypoglycemia are common. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.10.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331364PMC
December 2018
1 Read

Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice.

Ann Transl Med 2018 Dec;6(24):469

Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.

Inborn errors of metabolism (IEMs) are rare genetic or inherited disorders resulting from an enzyme defect in biochemical and metabolic pathways affecting proteins, fats, carbohydrates metabolism or impaired organelle function presenting as complicated medical conditions involving several human organ systems. They involve great complexity of the underlying pathophysiology, biochemical workup, and molecular analysis, and have complicated therapeutic options for management. Age of presentation can vary from infancy to adolescence with the more severe forms appearing in early childhood accompanied by significant morbidity and mortality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.12.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331353PMC
December 2018
1 Read

Inborn errors of metabolism in the 21 century: past to present.

Ann Transl Med 2018 Dec;6(24):467

Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

The 21 century is an exciting time to be in the field of metabolic medicine. As with many fields, one of the keys to anticipating the future is to understand the past. The term "inborn error of metabolism" was first coined in 1908 by Sir Archibald Garrod, in reference to four disorders (alkaptonuria, pentosuria, cystinuria and albinism). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2018.11.36DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331363PMC
December 2018

Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.

Orphanet J Rare Dis 2019 Feb 7;14(1):32. Epub 2019 Feb 7.

Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.

Background: Niemann-Pick disease Type C (NP-C) is a lysosomal lipid storage disorder characterized by progressive neurodegenerative symptomatology. The signs and symptoms of NP-C vary with age at disease onset, and available therapies are directed at alleviating symptoms and stabilizing disease progression. We report the characteristics and factors related to disease progression, and analyze the effect of miglustat treatment on disease progression and patient survival using NP-C disability scales. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-019-0996-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367842PMC
February 2019
1 Read

Translational Metabolism: A multidisciplinary approach towards precision diagnosis of inborn errors of metabolism in the omics era.

J Inherit Metab Dis 2018 Dec 27. Epub 2018 Dec 27.

Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Emma Children's Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

The laboratory diagnosis of inborn errors of metabolism has been revolutionized in recent years, thanks to the amazing developments in the field of DNA sequencing including whole exome and whole genome sequencing (WES and WGS). Interpretation of the results coming from WES and/or WGS analysis is definitely not trivial especially since the biological relevance of many of the variants identified by WES and/or WGS, have not been tested experimentally and prediction programs like POLYPHEN-2 and SIFT are far from perfect. Correct interpretation of WES and/or WGS results can only be achieved by performing functional studies at multiple levels (different metabolomics platforms, enzymology, in vitro and in vivo flux analysis), often requires studies in model organisms like zebra fish, Caenorhabditis elegans, Saccharomyces cerevisiae, mutant mice and others, and also requires the input of many different disciplines to make this Translational Metabolism approach effective. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jimd.12008DOI Listing
December 2018
2 Reads

Congestive Heart Failure in Children.

Authors:
Jack F Price

Pediatr Rev 2019 Feb;40(2):60-70

Department of Pediatrics, Baylor College of Medicine, and Advanced Heart Failure Unit, Texas Children's Hospital, Houston, TX.

Congestive heart failure is a final common clinical pathway for several diseases in childhood, such as familial cardiomyopathy, viral myocarditis, inborn errors of metabolism, and autoimmune disorders. Early identification and treatment can reduce symptom severity and may affect outcomes. In this review, the clinical characteristics of pediatric heart failure are described, and the initial diagnostic evaluation is outlined. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/pir.2016-0168DOI Listing
February 2019
1 Read

A retrospective study of small molecule disorder types of metabolism in paediatric patients in intensive care.

East Mediterr Health J 2019 Jan 23;24(11):1103-1111. Epub 2019 Jan 23.

Department of Paediatrics, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Background: Although inborn errors of metabolism (IEM) are rare individually, collectively IEM cause substantial morbidity and mortality and the diagnosis is challenging.

Aims: To analyse epidemiological and clinical data, final diagnosis and clinical outcomes of patients with a suspected diagnosis of IEM (small molecule disorders type) admitted to a paediatric intensive care unit (PICU).

Methods: We collected and analysed medical records data of all patients admitted to the PICU at Alexandria University Children's Hospital, from January 2010 to December 2014, with a suspected or confirmed diagnosis of small molecule disorders, including clinical presentations, laboratory results and clinical outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26719/emhj.18.056DOI Listing
January 2019
1 Read

Diagnosis of 'possible' mitochondrial disease: an existential crisis.

J Med Genet 2019 Jan 25. Epub 2019 Jan 25.

Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London, UK.

Primary genetic mitochondrial diseases are often difficult to diagnose, and the term 'possible' mitochondrial disease is used frequently by clinicians when such a diagnosis is suspected. There are now many known phenocopies of mitochondrial disease. Advances in genomic testing have shown that some patients with a clinical phenotype and biochemical abnormalities suggesting mitochondrial disease may have other genetic disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2018-105800DOI Listing
January 2019
2 Reads

Advances in inborn errors of metabolism.

J Hum Genet 2019 Feb 25;64(2):65. Epub 2019 Jan 25.

Kumamoto University, Department of Pediatrics, Kumamoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s10038-018-0535-7DOI Listing
February 2019

Disorders Affecting Vitamin B metabolism.

J Inherit Metab Dis 2019 Jan 22. Epub 2019 Jan 22.

Genetics and Genomic Medicine, UCL GOS Institute of Child Health, London WC1N 1EH, United Kingdom.

Vitamin B is present in our diet in many forms however only pyridoxal 5'-phosphate (PLP) can function as a cofactor for enzymes. The intestine absorbs non-phosphorylated B vitamers, which are converted by specific enzymes to the active PLP form. The role of PLP is enabled by its reactive aldehyde group. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jimd.12060
Publisher Site
http://dx.doi.org/10.1002/jimd.12060DOI Listing
January 2019
11 Reads

Recessive Rare Variants in Deoxyhypusine Synthase, an Enzyme Involved in the Synthesis of Hypusine, Are Associated with a Neurodevelopmental Disorder.

Am J Hum Genet 2019 Feb 17;104(2):287-298. Epub 2019 Jan 17.

Department of Pediatrics, Columbia University Medical Center, New York, NY 10032, USA; Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA. Electronic address:

Hypusine is formed post-translationally from lysine and is found in a single cellular protein, eukaryotic translation initiation factor-5A (eIF5A), and its homolog eIF5A2. Biosynthesis of hypusine is a two-step reaction involving the enzymes deoxyhypusine synthase (DHPS) and deoxyhypusine hydroxylase (DOHH). eIF5A is highly conserved throughout eukaryotic evolution and plays a role in mRNA translation, cellular proliferation, cellular differentiation, and inflammation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2018.12.017DOI Listing
February 2019
2 Reads

Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure.

Biochim Biophys Acta Mol Basis Dis 2019 Jan 15. Epub 2019 Jan 15.

Departments of Clinical Chemistry, Pediatrics and Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology & Metabolism, 1105 AZ Amsterdam, the Netherlands. Electronic address:

Pyrimidine nucleotides are essential for a vast number of cellular processes and dysregulation of pyrimidine metabolism has been associated with a variety of clinical abnormalities. Inborn errors of pyrimidine metabolism affecting enzymes in the pyrimidine de novo and degradation pathway have been identified but no patients have been described with a deficiency in proteins affecting the cellular import of ribonucleosides. In this manuscript, we report the elucidation of the genetic basis of the observed uridine-cytidineuria in a patient presenting with fever, hepatosplenomegaly, persistent lactate acidosis, severely disturbed liver enzymes and ultimately multi-organ failure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2019.01.013DOI Listing
January 2019
2 Reads

Infantile-onset inflammatory bowel disease in a patient with Hermansky-Pudlak syndrome: a case report.

BMC Gastroenterol 2019 Jan 11;19(1). Epub 2019 Jan 11.

Department of Pediatrics and Child Health, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.

Background: Hermansky-Pudlak syndrome (HPS) is a rare, genetically heterogeneous disorder that manifests oculocutaneous albinism together with bleeding diatheses that reflect a platelet storage pool deficiency. Ten genetic subtypes of this autosomal recessive condition have been described to date. Some patients with Hermansky-Pudlak syndrome type 1, 4, or 6 develop Crohn's-like inflammatory bowel disease at any age including early childhood, but most often in adolescence or young adulthood. Read More

View Article

Download full-text PDF

Source
https://bmcgastroenterol.biomedcentral.com/articles/10.1186/
Publisher Site
http://dx.doi.org/10.1186/s12876-019-0929-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329123PMC
January 2019
10 Reads

Hereditary diseases of coenzyme A thioester metabolism.

Biochem Soc Trans 2019 Jan 9. Epub 2019 Jan 9.

Division of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine and Université de Montréal, Montréal, QC, Canada

Coenzyme A (CoA) thioesters (acyl-CoAs) are essential intermediates of metabolism. Inborn errors of acyl-CoA metabolism include a large fraction of the classical organic acidemias. These conditions can involve liver, muscle, heart and brain, and can be fatal. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BST20180423DOI Listing
January 2019
1 Read

Clinical and genetic analysis of 7 Chinese patients with β-ureidopropionase deficiency.

Medicine (Baltimore) 2019 Jan;98(1):e14021

Institution of Pediatrics.

β-Ureidopropionase (βUP) deficiency is an autosomal recessive disease caused by abnormal changes in the pyrimidine-degradation pathway. This study aimed to investigate the mutation of β-ureidopropionase gene (UPB1) gene and clinical features of 7 Chinese patients with βUP deficiency.We reported 7 Chinese patients with βUP deficiency who were admitted at Tianjin Children's Hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344145PMC
January 2019
2 Reads

A novel mutation of SGSH and clinical features analysis of mucopolysaccharidosis type IIIA.

Medicine (Baltimore) 2018 Dec;97(52):e13758

Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, P.R. China.

Rationale: The aim of this study was to analyze the clinical and imaging features of a pediatric patient with mucopolysaccharidosis type IIIA (MPS IIIA) and a novel mutation of the N-sulfoglucosamine sulfohydrolase (SGSH) in 1 pedigree.

Patient Concerns: An 8-year-old female patient presented with developmental regression, seizures, cerebral atrophy, thickened calvarial diploe, apathy, esotropia, slender build, thick hair, prominent eyebrows, hepatomegaly, ankle clonus, muscle and joint contractures, and funnel chest.

Diagnoses: The patient was diagnosed as autosomal recessive (AR) MPS IIIA with a novel mutation in the SGSH gene. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201812280-0002
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000013758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314651PMC
December 2018
9 Reads

Inborn Errors of Metabolism: Gyrate Atrophy.

Adv Exp Med Biol 2018 ;1085:183-185

Department of Ophthalmology, Columbia University, Edward S. Harkness Eye Institute, NewYork-Presbyterian Hospital, New York, NY, USA.

Gyrate atrophy is an autosomal recessive dystrophy in which night blindness starts early in the first decade of life. In the early stages, large areas of retinal pigment epithelium (RPE) and choriocapillaris (CC) atrophy in the far periphery (lobular shape, Fig. 37. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-319-95046-4_37
Publisher Site
http://dx.doi.org/10.1007/978-3-319-95046-4_37DOI Listing
January 2018
5 Reads

Metabolic Evaluation of Epilepsy: A Diagnostic Algorithm With Focus on Treatable Conditions.

Front Neurol 2018 3;9:1016. Epub 2018 Dec 3.

Division of Genetics and Metabolism, Children's National Health System, Washington, DC, United States.

Although inborn errors of metabolism do not represent the most common cause of seizures, their early identification is of utmost importance, since many will require therapeutic measures beyond that of common anti-epileptic drugs, either in order to control seizures, or to decrease the risk of neurodegeneration. We translate the currently-known literature on metabolic etiologies of epilepsy (268 inborn errors of metabolism belonging to 21 categories, with 74 treatable errors), into a 2-tiered diagnostic algorithm, with the first-tier comprising accessible, affordable, and less invasive screening tests in urine and blood, with the potential to identify the majority of treatable conditions, while the second-tier tests are ordered based on individual clinical signs and symptoms. This resource aims to support the pediatrician, neurologist, biochemical, and clinical geneticists in early identification of treatable inborn errors of metabolism in a child with seizures, allowing for timely initiation of targeted therapy with the potential to improve outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2018.01016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286965PMC
December 2018
1 Read

Movement Disorders in Treatable Inborn Errors of Metabolism.

Mov Disord 2018 Dec 17. Epub 2018 Dec 17.

Department of Pediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

There are several hundred single-gene disorders that we classify as inborn errors of metabolism. Inborn errors of metabolism are often rare and highly heterogeneous multisystem diseases with non-neurological and neurological manifestations, commonly with onset during childhood. Movement disorders are among the most common neurological problems in inborn errors of metabolism, but, in many cases, remain poorly defined. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27568DOI Listing
December 2018

The Usefulness of Muscle Biopsy in Initial Diagnostic Evaluation of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

Yonsei Med J 2019 Jan;60(1):98-105

Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.

Purpose: The disease entity mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is characterized by an early onset of stroke-like episodes. MELAS is the most dominant subtype of mitochondrial disease. Molecular genetic testing is important in the diagnosis of MELAS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3349/ymj.2019.60.1.98DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298893PMC
January 2019
8 Reads

UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.

Medicine (Baltimore) 2018 Dec;97(49):e13576

Department of Pediatrics, Jinshan Hospital of Fudan University, Shanghai, China.

To retrospectively analyze and quantitatively correlate UGT1A1 (bilirubin UDP- glucuronosyltransferase gene) genotypes and unconjugated hyperbilirubinemia (UCH) phenotypes among Chinese children.We retrospectively reviewed UCH patients, quantitatively analyzed genotype-phenotype correlation by comparing with healthy controls. Pfam database, SWISS-model, and Pymol were used for UGT1A1 protein domain analysis and protein modeling for assessing the effect of novel missense variants on protein structure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310575PMC
December 2018
1 Read

A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.

Tohoku J Exp Med 2018 12;246(4):233-241

Department of Laboratory Animal Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.

Primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder, is characterized by renal stones, nephrocalcinosis, and chronic kidney disease. PH1 is caused by defects in alanine glyoxylate aminotransferase (AGT, 392 amino-acid residues), which is encoded by the alanine-glyoxylate and serine-pyruvate aminotransferase (AGXT) gene. This study aimed to determine the clinical, biochemical, and mutation spectrum of patients with PH1 from mainland China. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1620/tjem.246.233DOI Listing
December 2018
1.283 Impact Factor

Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients.

BMC Neurol 2018 Dec 12;18(1):203. Epub 2018 Dec 12.

FRIGE's Institute of Human Genetics, FRIGE House, Jodhpur Gam Road, Satellite, Ahmedabad, Gujarat, 380015, India.

Background: Neuronal ceroid lipofuscinoses type I and type II (NCL1 and NCL2) also known as Batten disease are the commonly observed neurodegenerative lysosomal storage disorder caused by mutations in the PPT1 and TPP1 genes respectively. Till date, nearly 76 mutations in PPT1 and approximately 140 mutations, including large deletion/duplications, in TPP1 genes have been reported in the literature. The present study includes 34 unrelated Indian patients (12 females and 22 males) having epilepsy, visual impairment, cerebral atrophy, and cerebellar atrophy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-018-1206-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292089PMC
December 2018
3 Reads

Subcellular localization of sterol biosynthesis enzymes.

J Mol Histol 2019 Feb 8;50(1):63-73. Epub 2018 Dec 8.

Department of Psychiatry and Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, NE, USA.

Cholesterol synthesis is a complex, coordinated process involving a series of enzymes. As of today, our understanding of subcellular localization of cholesterol biosynthesis enzymes is far from complete. Considering the complexity and intricacies of this pathway and the importance of functions of DHCR7, DHCR24 and EBP enzymes for human health, we undertook a study to determine their subcellular localization and co-localization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10735-018-9807-yDOI Listing
February 2019

Neonatal lethal hypophosphatasia: A case report and review of literature.

Medicine (Baltimore) 2018 Nov;97(48):e13269

Neonatal Service, Metabolic Unit, Department of Pediatrics, Santiago de Compostela University Hospital, IDIS (Health Research Institute of Santiago de Compostela), Ciberer, Spain.

Rationale: Hypophosphatasia (HPP) is a very rare metabolic bone disease caused by loss-of-function mutations in the ALPL gene encoding the tissue nonspecific alkaline phosphatase. The severe neonatal form is considered lethal but insights into manifestations of the disease can help to increase our knowledge of the natural history for an early initiation of treatment and improvement of survival.

Patient Concerns: We report the case of a newborn in which his fetal imaging showed findings of skeletal dysplasia disorder, considering initially achondroplasia as a potential diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283130PMC
November 2018
1 Read

Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1.

Cell Transplant 2018 Nov 26:963689718814188. Epub 2018 Nov 26.

1 Department of Surgery, Mayo Clinic, Rochester, MN, USA.

Orthotopic liver transplantation remains the only curative therapy for inborn errors of metabolism. Given the tremendous success for primary immunodeficiencies using ex-vivo gene therapy with lentiviral vectors, there is great interest in developing similar curative therapies for metabolic liver diseases. We have previously generated a pig model of hereditary tyrosinemia type 1 (HT1), an autosomal recessive disorder caused by deficiency of fumarylacetoacetate hydrolase (FAH). Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0963689718814188
Publisher Site
http://dx.doi.org/10.1177/0963689718814188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322137PMC
November 2018
9 Reads

Combined liver-kidney transplantation for primary hyperoxaluria type I in children: Single Center Experience.

Pediatr Transplant 2019 02 26;23(1):e13313. Epub 2018 Nov 26.

Pediatric Hepatology Unit, Faculty of Medicine, Department of Pediatrics, Cairo University, Cairo, Egypt.

Primary hyperoxalurias are rare inborn errors of metabolism with deficiency of hepatic enzymes that lead to excessive urinary oxalate excretion and overproduction of oxalate which is deposited in various organs. Hyperoxaluria results in serious morbid-ity, end stage kidney disease (ESKD), and mortality if left untreated. Combined liver kidney transplantation (CLKT) is recognized as a management of ESKD for children with hyperoxaluria type 1 (PH1). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.13313DOI Listing
February 2019
3 Reads

Laboratory analysis of amino acids, 2018 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Genet Med 2018 12 19;20(12):1499-1507. Epub 2018 Oct 19.

Laboratory Corporation of America® Holdings (LabCorp), Durham, NC, USA.

Amino acid abnormalities are observed in a broad spectrum of inherited metabolic diseases, such as disorders of amino acid metabolism and transport, organic acidemias, and ureagenesis defects. Comprehensive analysis of physiologic amino acids in blood, urine, and cerebrospinal fluid is typically performed in the following clinical settings: evaluation of symptomatic patients in whom a diagnosis is not known; evaluation of previously diagnosed patients to monitor treatment efficacy; evaluation of asymptomatic or presymptomatic (at-risk) relatives of known patients; follow-up testing for an abnormal newborn screen; and assessment of dietary protein adequacy or renal function in general patient populations. Currently, the most common analytical method to quantify amino acids is based on ion exchange chromatography using post-column derivatization with ninhydrin and spectrophotometric detection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-018-0328-6DOI Listing
December 2018
10 Reads

Mutation analysis and pathogenicity identification of Mucopolysaccharidosis type IVA in 8 south China families.

Gene 2019 Feb 17;686:261-269. Epub 2018 Nov 17.

Department of Medical Genetics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. Electronic address:

Background: Mucopolysaccharidosis type IVA (MPS IVA) is a rare autosomal recessive lysosomal storage disorder caused by GALNS gene mutation. The aim of our study is to detect pathogenic variants for patients suspected of MPS IVA and set the base for subsequent prenatal diagnosis and preimplantation genetic diagnosis.

Methods: In our study, 9 MPS IVA patients from south China families were investigated. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03781119183119
Publisher Site
http://dx.doi.org/10.1016/j.gene.2018.11.051DOI Listing
February 2019
14 Reads

Fanconi Syndrome.

Authors:
John W Foreman

Pediatr Clin North Am 2019 02;66(1):159-167

Department of Pediatrics, Duke University School of Medicine, Erwin Road, Durham, NC 27710, USA. Electronic address:

Fanconi syndrome, also known as the DeToni, Debré, Fanconi syndrome is a global dysfunction of the proximal tubule characterized by glucosuria, phosphaturia, generalized aminoaciduria, and type II renal tubular acidosis. Often there is hypokalemia, sodium wasting, and dehydration. In children, it typically is caused by inborn errors of metabolism, principally cystinosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcl.2018.09.002DOI Listing
February 2019
1 Read

Renal Tubular Acidosis.

Pediatr Clin North Am 2019 02;66(1):135-157

Division of Nephrology, Department of Pediatrics, The Montreal Children's Hospital, McGill University Health Centre, Room B RC.6651, Montreal, Quebec H4A 3J1, Canada; Al Jalila Children's Hospital, Al Jadaf PO Box 7662, Dubai, UAE. Electronic address:

Renal tubular acidosis should be suspected in poorly thriving young children with hyperchloremic and hypokalemic normal anion gap metabolic acidosis, with/without syndromic features. Further workup is needed to determine the type of renal tubular acidosis and the presumed etiopathogenesis, which informs treatment choices and prognosis. The risk of nephrolithiasis and calcinosis is linked to the presence (proximal renal tubular acidosis, negligible stone risk) or absence (distal renal tubular acidosis, high stone risk) of urine citrate excretion. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313955183013
Publisher Site
http://dx.doi.org/10.1016/j.pcl.2018.08.011DOI Listing
February 2019
13 Reads
2.198 Impact Factor

Bartter Syndrome and Gitelman Syndrome.

Pediatr Clin North Am 2019 02;66(1):121-134

Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address:

Bartter and Gitelman syndromes are conditions characterized by renal salt-wasting. Clinical presentations range from severe antenatal disease to asymptomatic with incidental diagnosis. Hypokalemic hypochloremic metabolic alkalosis is the common feature. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00313955183013
Publisher Site
http://dx.doi.org/10.1016/j.pcl.2018.08.010DOI Listing
February 2019
10 Reads

Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.

Hum Genet 2018 Dec 19;137(11-12):921-939. Epub 2018 Nov 19.

Warren Alpert Medical School of Brown University, Providence, RI, USA.

Juvenile segmental progeroid syndromes are rare, heterogeneous disorders characterized by signs of premature aging affecting more than one tissue or organ starting in childhood. Hutchinson-Gilford progeria syndrome (HGPS), caused by a recurrent de novo synonymous LMNA mutation resulting in aberrant splicing and generation of a mutant product called progerin, is a prototypical example of such disorders. Here, we performed a joint collaborative study using massively parallel sequencing and targeted Sanger sequencing, aimed at delineating the underlying genetic cause of 14 previously undiagnosed, clinically heterogeneous, non-LMNA-associated juvenile progeroid patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-018-1957-1DOI Listing
December 2018
6 Reads
4.824 Impact Factor

Pharmacological treatment of pediatric Gaucher disease.

Expert Rev Clin Pharmacol 2018 Dec 3;11(12):1183-1194. Epub 2018 Dec 3.

b Department of Medicine (Genetics) , University College Dublin , Dublin , Ireland.

Introduction: Gaucher disease (GD) is an autosomal recessive disorder resulting from the deficiency of the lysosomal enzyme glucocerebrosidase (b-glucosidase), associated with varying degrees of visceral, bone and central nervous system pathology, leading to wide phenotypic diversity. Response to therapy and clinical outcomes are very different between the three clinical subtypes - non-neuronopathic, acute neuronopathic, and chronic neuronopathic forms; hence a definitive clinical diagnosis is essential. The availability of two therapeutic options, i. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17512433.2018.1549486DOI Listing
December 2018
7 Reads

Progressive Feeding Intolerance Secondary to a Congenital Spinal Teratoma in a Four-week-old Female.

Cureus 2018 Sep 11;10(9):e3281. Epub 2018 Sep 11.

Pediatrics, University of Illinois College of Medicine At Peoria, Peoria, USA.

A poorly feeding neonate presents the clinician with a diagnostic challenge. Feeding difficulties and irritability may be due to sepsis, congenital heart disease, inborn errors of metabolism, non-accidental head trauma, as well as a vast variety of other pathologies. Teratomas are rare pediatric tumors that can occasionally present in the immediate neonatal period and can manifest in the infant's central nervous system (CNS) with non-specific symptoms of poor feeding, lethargy, and somnolence. Read More

View Article

Download full-text PDF

Source
https://www.cureus.com/articles/13804-progressive-feeding-in
Publisher Site
http://dx.doi.org/10.7759/cureus.3281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235640PMC
September 2018
9 Reads

Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Early Diagnosis Consensus (GED-C) Delphi initiative.

Intern Med J 2018 Nov 10. Epub 2018 Nov 10.

Shaare Zedek Medical Center and Hadassah Medical School, Jerusalem, Israel.

Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognize the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities.

Aims: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify 'at-risk' patients who may benefit from diagnostic testing. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/imj.14156
Publisher Site
http://dx.doi.org/10.1111/imj.14156DOI Listing
November 2018
19 Reads
1.699 Impact Factor

Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.

J Pediatr 2019 Feb 6;205:176-182. Epub 2018 Nov 6.

Neonatal Screening Center, The Chinese Foundation of Health, Taipei, Taiwan. Electronic address:

Objective: To evaluate the initial cutoff values, rates of screen positives, and genotypes for the large-scale newborn screening program for multiple mucopolysaccharidoses (MPS) in Taiwan.

Study Design: More than 100 000 dried blood spots were collected consecutively as part of the national Taiwan newborn screening programs. Enzyme activities were measured by tandem mass spectrometry from dried blood spot punches. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00223476183139
Publisher Site
http://dx.doi.org/10.1016/j.jpeds.2018.09.063DOI Listing
February 2019
8 Reads
3.790 Impact Factor

The current landscape of European registries for rare endocrine conditions.

Eur J Endocrinol 2019 Jan;180(1):89-98

Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, UK.

Objective To identify cross-border international registries for rare endocrine conditions that are led from Europe and to understand the extent of engagement with these registries within a network of reference centres (RCs) for rare endocrine conditions. Methods Database search of international registries and a survey of RCs in the European Reference Network for rare endocrine conditions (Endo-ERN) with an overall response rate of 82%. Results Of the 42 conditions with orphacodes currently covered within Endo-ERN, international registries exist for 32 (76%). Read More

View Article

Download full-text PDF

Source
https://eje.bioscientifica.com/view/journals/eje/aop/eje-18-
Publisher Site
http://dx.doi.org/10.1530/EJE-18-0861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347278PMC
January 2019
15 Reads

Renal replacement therapy in neonates with an inborn error of metabolism.

Authors:
Heeyeon Cho

Korean J Pediatr 2019 Feb 7;62(2):43-47. Epub 2018 Nov 7.

Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Hyperammonemia can be caused by several genetic inborn errors of metabolism including urea cycle defects, organic acidemias, fatty acid oxidation defects, and certain disorders of amino acid metabolism. High levels of ammonia are extremely neurotoxic, leading to astrocyte swelling, brain edema, coma, severe disability, and even death. Thus, emergency treatment for hyperammonemia must be initiated before a precise diagnosis is established. Read More

View Article

Download full-text PDF

Source
http://kjp.or.kr/journal/view.php?doi=10.3345/kjp.2018.07143
Publisher Site
http://dx.doi.org/10.3345/kjp.2018.07143DOI Listing
February 2019
9 Reads

A Screen Using iPSC-Derived Hepatocytes Reveals NAD as a Potential Treatment for mtDNA Depletion Syndrome.

Cell Rep 2018 Nov;25(6):1469-1484.e5

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA; Hollings Cancer Center, Medical University of South Carolina, 86 Jonathan Lucas Street, Charleston, SC 29425, USA. Electronic address:

Patients with mtDNA depletion syndrome 3 (MTDPS3) often die as children from liver failure caused by severe reduction in mtDNA content. The identification of treatments has been impeded by an inability to culture and manipulate MTDPS3 primary hepatocytes. Here we generated DGUOK-deficient hepatocyte-like cells using induced pluripotent stem cells (iPSCs) and used them to identify drugs that could improve mitochondrial ATP production and mitochondrial function. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247183161
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2018.10.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289059PMC
November 2018
21 Reads

Cofactors revisited - Predicting the impact of flavoprotein-related diseases on a genome scale.

Biochim Biophys Acta Mol Basis Dis 2019 Feb 29;1865(2):360-370. Epub 2018 Oct 29.

Systems and Synthetic Biology, Wageningen University & Research, 6708, WE, Wageningen, the Netherlands. Electronic address:

Flavin adenine dinucleotide (FAD) and its precursor flavin mononucleotide (FMN) are redox cofactors that are required for the activity of more than hundred human enzymes. Mutations in the genes encoding these proteins cause severe phenotypes, including a lack of energy supply and accumulation of toxic intermediates. Ideally, patients should be diagnosed before they show symptoms so that treatment and/or preventive care can start immediately. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09254439183039
Publisher Site
http://dx.doi.org/10.1016/j.bbadis.2018.10.021DOI Listing
February 2019
1 Read

Basal pharmacokinetic parameters of topically applied diacerein in pediatric patients with generalized severe epidermolysis bullosa simplex.

Orphanet J Rare Dis 2018 Nov 1;13(1):193. Epub 2018 Nov 1.

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

Generalized severe epidermolysis bullosa simplex (EBS-gen sev) is caused by mutations within either the KRT5 or KRT14 gene, phenotypically resulting in blistering and wounding of the skin and mucous membranes after minor mechanical friction. In a clinical phase 2/3 trial, diacerein has recently been shown to significantly reduce blister numbers upon topical application. In this study we addressed basic pharmacokinetic parameters of locally applied diacerein in vitro and in vivo. Read More

View Article

Download full-text PDF

Source
https://ojrd.biomedcentral.com/articles/10.1186/s13023-018-0
Publisher Site
http://dx.doi.org/10.1186/s13023-018-0940-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211505PMC
November 2018
3 Reads

Behavioral and Emotional Problems in Early-Treated Brazilian Children and Adolescents with Phenylketonuria.

Med Sci Monit 2018 Oct 30;24:7759-7769. Epub 2018 Oct 30.

Institute of Childcare and Pediatrics "Martagão Gesteira", Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

BACKGROUND Phenylketonuria (PKU) is an inborn error of metabolism caused by mutations in the phenylalanine hydroxylase (PAH) gene. When untreated, PKU leads to a significant intellectual deficiency. Although early initiation of dietary therapy allows normal cognitive development, low adherence to treatment may result in neuropsychological deficits, including attention problems. Read More

View Article

Download full-text PDF

Source
https://www.medscimonit.com/abstract/index/idArt/909146
Publisher Site
http://dx.doi.org/10.12659/MSM.909146DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354646PMC
October 2018
16 Reads

A Novel Clinico-Biochemical Score for Screening of Inherited Metabolic Diseases in Children.

J Coll Physicians Surg Pak 2018 Nov;28(11):853-857

Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan.

Objective: To evaluate a novel clinico-biochemical score for screening of inherited metabolic diseases (IMDs) in children in our setup.

Study Design: Descriptive analytical study.

Place And Duration Of Study: Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology, Rawalpindi, from August 2016 to August 2017. Read More

View Article

Download full-text PDF

Source
https://www.jcpsp.pk/archive/2018/Nov2018/10.pdf
Publisher Site
http://dx.doi.org/10.29271/jcpsp.2018.11.853DOI Listing
November 2018
73 Reads
0.320 Impact Factor